staceywhite, Author at European Medical Journal - Page 127 of 194

β-Thalassaemias: Highlights from the European Hematology Association Scientific Working Group (EHA-SWG) Scientific Meeting on Anaemias: Diagnosis and Treatment in the Omics Era

β-thalassaemias are inherited blood disorders caused by a defect in the production of β-globin, giving rise to variable phenotypes.

Innovative Gene Therapy for Duchenne Muscular Dystrophy

INJECTED microdystrophin restores muscle strength and clinical symptoms in dogs with Duchenne muscular dystrophy, according to new research. This…

Nanotechnology Device Transforms Skin Cells into Any Organ

GROUNDBREAKING research by an American team has revealed a successful method of restoring damaged organs using a single small chip. This breakthrough in…

Kidney Graft Survival Unaffected by Donor Age

GRAFT SURVIVAL rate of a transplanted kidney is similar for kidneys from both donors aged >80 years and donors ≤60 years of age, according to…

Kidney Function Decline Linked to Atrial Fibrillation Risk

DECREASED kidney function is associated with a greater chance of atrial fibrillation development, new research suggests. Due to the poor clinical outcome…

Internet Trends Elucidate the Link Between Weather Conditions and Joint Pain

INDIVIDUALS with joint pain or arthritis have almost proverbially associated weather conditions with varying levels of pain. However, research undertaken…

Largest Ever Sample Study on Arthritis Yields Interesting Results

TODAY, the average American is twice as likely to be diagnosed with knee osteoarthritis than in the years leading up to World War II, according to a…

How I Manage Myelofibrosis

Myelofibrosis (MF), either primary or secondary to polycythaemia vera or essential thrombocythaemia, is the most symptomatic and has the worst prognosis…

How I Diagnose Hypereosinophilic Syndromes

Hypereosinophilic syndromes are a group of disorders characterised by significant eosinophilia and organ damage.

Management of Multiply Relapsed Aggressive Non-Hodgkin Lymphoma: New Perspectives

Patients with refractory/relapsed (R/R) non-Hodgkin lymphoma (NHL) make up a very heterogeneous population with a poor life expectancy.